BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune diseases, ...

GT-02287 oral presentation demonstrates new evidence of disease-modifying capacity in GBA1 and idiopathic Parkinson's disease ...

The glove box market is propelled by increasing demand across industries such as pharmaceuticals, healthcare, semiconductors, and nuclear research, where controlled environments are essential. Rising ...

Poster presentation details: All regular abstracts are available for viewing via AACR’s online itinerary planner located, here. About Tempest Therapeutics Tempest Therapeutics is a clinical-stage ...

MINDFuL Phase II Blinded, Randomized, Placebo-Controlled Data Anticipated June 2025 Boca Raton, Florida, April 01, 2025 (GLOBE NEWSWIRE) -- ...

Vietnam’s leading trade fair for laboratory technology, analysis, biotechnology, and diagnostics - analytica Vietnam 2025 - ...

Zymeworks scientists are coauthors on two additional presentations leveraging technologies to aid further in design and characterizations of ... selection Zymeworks is a global clinical-stage ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver ...

MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial ...

March 31, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging ... "When I look across the design of these two molecules, the preclinical ...